What is the share price of Health X Platform Ltd (HEALTHX) today?
The share price of HEALTHX as on 7th May 2026 is ₹289.95. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Health X Platform Ltd (HEALTHX) share?
The past returns of Health X Platform Ltd (HEALTHX) share are- Past 1 week: 2.38%
- Past 1 month: 6.82%
- Past 3 months: -2.78%
- Past 6 months: 0.10%
- Past 1 year: 16.84%
- Past 3 years: 21.47%
- Past 5 years: 70.16%
What are the peers or stocks similar to Health X Platform Ltd (HEALTHX)?
The peers or stocks similar to Health X Platform Ltd (HEALTHX) include:What is the market cap of Health X Platform Ltd (HEALTHX) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Health X Platform Ltd (HEALTHX) is ₹904.21 Cr as of 7th May 2026.What is the 52 week high and low of Health X Platform Ltd (HEALTHX) share?
The 52-week high of Health X Platform Ltd (HEALTHX) is ₹363 and the 52-week low is ₹241.60.What is the PE and PB ratio of Health X Platform Ltd (HEALTHX) stock?
The P/E (price-to-earnings) ratio of Health X Platform Ltd (HEALTHX) is -9.92. The P/B (price-to-book) ratio is 1.05.Which sector does Health X Platform Ltd (HEALTHX) belong to?
Health X Platform Ltd (HEALTHX) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Health X Platform Ltd (HEALTHX) shares?
You can directly buy Health X Platform Ltd (HEALTHX) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Health X Platform Ltd
HEALTHX Share Price
NSE₹289.952.01% (+5.70)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
HEALTHX Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
HEALTHX Performance & Key Metrics
HEALTHX Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 34.76 | 1.05 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 41.10 | 6.15 | 0.54% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
HEALTHX Company Profile
Health X Platform Limited operates digital healthcare networks offering pharmacy, diagnostics, wellness products, pathology, radiology, and financial services including loans, wealth management, and financial consultancy in India.
PE Ratio
57.44
57.44
1Y Return
16.48%
16.48%
Buy Reco %
87.50
87.50
POLYMED
PE Ratio
49.57
49.57
1Y Return
40.75%
40.75%
Buy Reco %
80.00
80.00
TARSONS
PE Ratio
40.80
40.80
1Y Return
36.91%
36.91%
Buy Reco %
100.00
100.00
LAXMIDENTL
PE Ratio
37.04
37.04
1Y Return
43.64%
43.64%
Buy Reco %
100.00
100.00
BOROSCI
PE Ratio
40.41
40.41
1Y Return
2.13%
2.13%
Buy Reco %
0.00
0.00
HEALTHX Sentiment Analysis
HEALTHX Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
HEALTHX Stock Summary · February 2026
In Q3 FY26, the company demonstrated robust financial recovery, achieving a profit after tax of Rs. 11 crores, a significant turnaround from the previous year's loss, driven by improved operational efficiency and strategic investments in technology. With a focus on enhancing customer experience through innovative platforms like Retailer Shakti and JITO, the company is poised for sustainable growth, targeting a compound annual growth rate exceeding 30% over the next decade. Despite challenges from increased GST rates and competitive pressures, the management remains optimistic about maintaining strong margins and capital efficiency, leveraging its unique market positioning and expanding warehouse capabilities to meet rising demand. The upcoming merger and demerger initiatives are expected to further streamline operations and enhance investor confidence, solidifying the company's leadership in the healthcare sector.
HEALTHX Stock Growth Drivers
HEALTHX Stock Growth Drivers
7Strong Financial Performance
SastaSundar Ventures Limited reported significant financial achievements, including a 22% year-on-year revenue increase in Q3
Operational Efficiency and Growth
The company demonstrated strong operational traction with improvements in resourcing, procurement optimization, and automation in
HEALTHX Stock Challenges
HEALTHX Stock Challenges
5Working Capital Challenges
The company faces pressures on working capital, which, while manageable, indicate potential liquidity concerns. The
Lower Gross Margins Compared to Competitors
The company's gross margin is reported at 7.6%, which is lower than competitors in the
HEALTHX Forecast
HEALTHX Forecasts
Price
Revenue
Earnings
HEALTHX Share Price Forecast
HEALTHX Share Price Forecast
2026
Current
₹289.95
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹289.95
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
HEALTHX Company Revenue Forecast
HEALTHX Company Revenue Forecast
2025
Current
₹1.17
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.17
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
HEALTHX Stock EPS (Earnings Per Share) Forecast
HEALTHX Stock EPS (Earnings Per Share) Forecast
2025
Current
₹-28.66
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹-28.66
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
HEALTHX
HEALTHX
Income
Balance Sheet
Cash Flow
Quarterly Normal View
HEALTHX Income Statement
HEALTHX Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 368.20 | 394.63 | 325.13 | 299.04 | 295.82 | 269.46 | 307.75 | 323.81 | 306.83 | 359.35 | ||||||||||
Operating & Other expenses | 355.35 | 371.30 | 317.59 | 272.80 | 468.01 | 307.26 | 311.03 | 292.46 | 324.15 | 356.27 | ||||||||||
EBITDA | 12.85 | 23.33 | 7.54 | 26.24 | -172.19 | -37.80 | -3.28 | 31.35 | -17.32 | 3.08 | ||||||||||
| Depreciation/Amortization | 2.20 | 2.31 | 2.53 | 1.61 | 1.45 | 1.43 | 1.34 | 1.17 | 1.33 | 2.17 | ||||||||||
| PBIT | 10.65 | 21.02 | 5.01 | 24.63 | -173.64 | -39.23 | -4.62 | 30.18 | -18.65 | 0.91 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | 10.65 | 21.02 | 5.01 | 24.63 | -173.64 | -39.23 | -4.62 | 30.18 | -18.65 | 0.91 | ||||||||||
| Taxes & Other Items | 18.76 | 21.75 | -11.41 | -6.52 | -64.21 | -12.31 | -18.30 | 6.27 | -5.95 | -0.21 | ||||||||||
| Net Income | -8.11 | -0.73 | 16.42 | 31.15 | -109.43 | -26.92 | 13.68 | 23.91 | -12.70 | 1.12 | ||||||||||
| EPS | -2.55 | -0.23 | 5.17 | 9.79 | -34.40 | -8.47 | 4.30 | 7.52 | -3.99 | 0.35 |
HEALTHX Company Updates
FY 2026FY 2026
Investor Presentation
Feb 6PDF
Feb 6PDF
Nov 13PDF
Aug 16PDF
HEALTHX Stock Peers
HEALTHX Past Performance & Peer Comparison
HEALTHX Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Health X Platform Ltd | -9.92 | 1.05 | — |
| Inventurus Knowledge Solutions Ltd | 57.44 | 15.60 | — |
| Poly Medicure Ltd | 49.57 | 6.07 | 0.21% |
| Tarsons Products Ltd | 40.80 | 1.93 | — |
HEALTHX Stock Price Comparison
Compare HEALTHX with any stock or ETFCompare HEALTHX with any stock or ETF
HEALTHX
HEALTHX Holdings
HEALTHX Shareholdings
HEALTHX Promoter Holdings Trend
HEALTHX Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
HEALTHX Institutional Holdings Trend
HEALTHX Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
HEALTHX Shareholding Pattern
HEALTHX Shareholding Pattern
HEALTHX Shareholding History
HEALTHX Shareholding History
Foreign Institutions
Mutual Funds Invested in HEALTHX
Mutual Funds Invested in HEALTHX
No mutual funds holding trends are available
Top 1 Mutual Funds holding Health X Platform Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0003% | Percentage of the fund’s portfolio invested in the stock 0.02% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 121/130 (-5) |
Compare 3-month MF holding change on Screener
smallcases containing HEALTHX stock
smallcases containing HEALTHX stock
Looks like this stock is not in any smallcase yet.
HEALTHX Events
HEALTHX Events
HEALTHX Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
HEALTHX has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
HEALTHX Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
HEALTHX has not given any dividends in last 5 years
HEALTHX Upcoming Dividends
HEALTHX Upcoming Dividends
No upcoming dividends are available
HEALTHX Past Dividends
HEALTHX Past Dividends
Cash Dividend
Ex DateEx DateJul 23, 2012
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 23, 2012
Cash Dividend
Ex DateEx DateJul 25, 2011
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 25, 2011
HEALTHX Stock News & Opinions
HEALTHX Stock News & Opinions
Articles & Videos
Earnings
Sastasundar Ventures reports consolidated net profit of Rs 1.13 crore in the December 2025 quarter
Net profit of Sastasundar Ventures reported to Rs 1.13 crore in the quarter ended December 2025 as against net loss of Rs 26.94 crore during the previous quarter ended December 2024. Sales rose 22.91% to Rs 345.74 crore in the quarter ended December 2025 as against Rs 281.29 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales345.74281.29 23 OPM %-3.00-8.43 - PBDT3.09-35.58 LP PBT0.92-37.01 LP NP1.13-26.94 LP Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Sastasundar Ventures announces board meeting date
Sastasundar Ventures will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Sastasundar Ventures reports consolidated net loss of Rs 12.69 crore in the September 2025 quarter
Net Loss of Sastasundar Ventures reported to Rs 12.69 crore in the quarter ended September 2025 as against net loss of Rs 109.41 crore during the previous quarter ended September 2024. Sales rose 10.16% to Rs 301.32 crore in the quarter ended September 2025 as against Rs 273.53 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales301.32273.53 10 OPM %-7.50-1.73 - PBDT-17.1417.51 PL PBT-18.4716.05 PL NP-12.69-109.41 88 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Sastasundar Ventures to conduct board meeting
Sastasundar Ventures will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Sastasundar Ventures to convene AGM
Sastasundar Ventures announced that the 36th Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Sastasundar Ventures consolidated net profit declines 23.24% in the June 2025 quarter
Net profit of Sastasundar Ventures declined 23.24% to Rs 23.91 crore in the quarter ended June 2025 as against Rs 31.15 crore during the previous quarter ended June 2024. Sales rose 10.41% to Rs 298.43 crore in the quarter ended June 2025 as against Rs 270.29 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales298.43270.29 10 OPM %2.03-0.89 - PBDT31.3525.25 24 PBT30.1923.64 28 NP23.9131.15 -23 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Sastasundar Ventures to hold board meeting
Sastasundar Ventures will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Sastasundar Ventures consolidated net profit declines 16.85% in the March 2025 quarter
Net profit of Sastasundar Ventures declined 16.85% to Rs 13.67 crore in the quarter ended March 2025 as against Rs 16.44 crore during the previous quarter ended March 2024. Sales declined 6.79% to Rs 285.84 crore in the quarter ended March 2025 as against Rs 306.67 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 91.17 crore in the year ended March 2025 as against net profit of Rs 8.88 crore during the previous year ended March 2024. Sales declined 19.25% to Rs 1110.95 crore in the year ended March 2025 as against Rs 1375.71 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales285.84306.67 -7 1110.951375.71 -19 OPM %-8.81-3.47 --5.040.39 - PBDT-3.587.54 PL 3.6064.82 -94 PBT-4.915.01 PL -2.2355.68 PL NP13.6716.44 -17 -91.178.88 PL Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Sastasundar Ventures schedules board meeting
Sastasundar Ventures will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
Earnings
Sastasundar Ventures reports consolidated net loss of Rs 26.94 crore in the December 2024 quarter
Net Loss of Sastasundar Ventures reported to Rs 26.94 crore in the quarter ended December 2024 as against net loss of Rs 0.75 crore during the previous quarter ended December 2023. Sales declined 24.89% to Rs 281.29 crore in the quarter ended December 2024 as against Rs 374.50 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales281.29374.50 -25 OPM %-8.430.92 - PBDT-35.5823.32 PL PBT-37.0121.00 PL NP-26.94-0.75 -3492 Powered by Capital Market - Live
1 year agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 24.69%, vs industry avg of 24.67%
Over the last 5 years, market share decreased from 15.68% to 13.75%